Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
about
A novel genotype of GB virus C: its identification and predominance among injecting drug users in Yunnan, ChinaHepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implicationMolecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern ChinaFactors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern ChinaUnderlying Pathophysiology of HCV Infection in HIV-Positive Drug UsersHigh prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in ChinaComparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border regionHCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in ChinaHCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analysesHigh prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, ChinaEmerging variability in HIV-1 genetics among recently infected individuals in Yunnan, ChinaHigh prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, ChinaHIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern ChinaGenotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Hubei, Central ChinaThe Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in ChinaMultiple Introduction and Naturally Occuring Drug Resistance of HCV among HIV-Infected Intravenous Drug Users in Yunnan: An Origin of China's HIV/HCV EpidemicsNatural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naïve HIV/HCV Co-Infected Patients in ChinaThe current hepatitis C virus prevalence in China may have resulted mainly from an officially encouraged plasma campaign in the 1990s: a coalescence inference with genetic sequencesThe unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, ChinaCo-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlatesMigration patterns of hepatitis C virus in China characterized for five major subtypes based on samples from 411 volunteer blood donors from 17 provinces and municipalities.Significance of blood analysis in hemophiliacs co-infected with human immunodeficiency virus and hepatitis viruses.HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis.Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09.New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors.A new migration map of HIV-1 CRF07_BC in China: analysis of sequences from 12 provinces over a decade.The genetic diversity and evolutionary history of hepatitis C virus in VietnamHIV and hepatitis C virus test uptake at methadone clinics in Southern China: opportunities for expanding detection of bloodborne infectionsHigh rate of seronegative HCV infection in HIV-positive patients.Molecular and contextual markers of hepatitis C virus and drug abuse.Genotypic distribution and hepatic fibrosis among HIV/HCV co-infected individuals in Southern China: a retrospective cross-sectional studyHigh Prevalence of Hepatitis C virus Among Injection Drug Users in Zhenjiang, Jiangsu, ChinaSystematic review of HIV and HCV infection among drug users in China.Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management.Exploratory social network analysis and gene sequencing in people who inject drugs infected with hepatitis C virus.Subtype distribution of hepatitis C virus in Jiangsu, China.Effective epitope identification employing phylogenetic, mutational variability, sequence entropy, and correlated mutation analysis targeting NS5B protein of hepatitis C virus: from bioinformatics to therapeutics.Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.
P2860
Q21560806-14F9F40F-44AC-4141-B035-07DE883673FDQ27024231-71B17F96-7E9D-4574-A772-16082A3F20FDQ27487103-0158619A-1F48-4391-A787-46169D9F4573Q27488825-DE10B83F-B9A8-4852-BF15-B6C8AEC680B7Q27489073-BA90590B-8964-40AB-809C-283834D47111Q28474105-36AF2595-FD5B-48E6-A79A-A6C7A384251AQ28476802-5F1F775B-9A44-4481-8F3F-F480BE1A1680Q28477079-B1EA74BA-5F1C-4C1E-9A1F-14EE93EA977FQ28478744-5D7B41C7-4CE5-45F2-9FA6-0C667D51638BQ28482312-AEE0D784-3206-4154-B7C1-045F973A5159Q28488916-C56C1364-E72E-480D-AABE-59E486445BB3Q28534213-58BA9943-6B7D-4B87-88CA-A4DBF9E85E16Q28534659-32958195-73A3-4E07-9C4D-D8568998FEA0Q28547657-7D932423-5376-4F8B-9E0C-E466119975ECQ28550281-34DCFFEF-AD47-43FA-9642-1A2EBA73C9A7Q28550924-536C95CF-3FEB-463F-8307-AE4AE0D87329Q28552134-E9C02D37-F20B-4E3C-889A-EEE6931EECB0Q28662145-81A1F477-A3B8-400E-B162-426620B7865EQ28744366-4004796F-52B2-456F-8992-B1D298DDDED7Q33576933-61842A9F-6A7C-4770-A4FF-E48B2B8E21E6Q33744064-0ED69FD7-976B-4899-9BBB-C20A4923A293Q34112268-2574B908-C9BF-4C04-A64C-70AFAE95A0B4Q34297996-4664203C-8874-4222-A7B7-7D1DDB263651Q34354340-A22553F6-0D51-4FD3-81F1-98BA8BE2C004Q34486897-9A0B2AE2-2F17-49F9-9D08-9439D7402A0FQ34540632-6AEAC2DF-FDB3-4FE3-B128-681DBB03282CQ34615527-5469DA02-528D-4277-8277-69BC2BC33264Q35002184-727F5995-6EE4-4274-AB7C-AAFF0C2C2F14Q35125655-905A74D0-68CE-46F0-A33A-B778AE5DBD18Q35660841-D6CF516E-9CA4-406A-9352-A7D91A2987BAQ36110233-C50F1E50-E6CB-4F52-8871-CED8F82CB924Q36550056-A9A87D7E-1DB7-4622-997F-F6F057F2C923Q37487292-8ED88D6F-BDD8-41A8-B36B-0684DA30F616Q38180719-B55333FA-D8BB-40F4-9A95-8A00EDC9005EQ39609606-D1605581-B3E7-4AFE-BE1B-551384045E6AQ40627310-4A6B7C1E-9F20-4A2D-9940-83BCC6AE8EBEQ41332304-DB54AF6D-AD74-4227-81AB-9AD960AB22C5Q42982907-13D8B747-2E94-4A4B-8F06-DE1A5C583ED6Q42990814-3E277EEC-6042-44A2-B205-6B801A95C74EQ42997917-18F60816-9FBA-428B-AFD2-9B368A457D1C
P2860
Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
@en
type
label
Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
@en
prefLabel
Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
@en
P2093
P2860
P356
P1476
Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
@en
P2093
Jinbing Zhang
Rebecca J Garten
Shenghan Lai
Xiao-Fang Yu
P2860
P304
P356
10.1086/429491
P407
P478
41 Suppl 1
P577
2005-07-01T00:00:00Z